AKI - Nursing Case Study

Pathophysiology

• Primary mechanism: Decreased renal perfusion leads to prerenal acute kidney injury (AKI) by impairing blood flow to the kidneys, reducing glomerular filtration rate (GFR), and causing buildup of waste products. This can be due to conditions like hypotension, dehydration, or heart failure.

• Secondary mechanism: Direct damage to kidney tissues, known as intrinsic renal AKI, can occur due to nephrotoxic substances (e.g., certain medications or contrast dye) or acute tubular necrosis, damaging renal tubules and further decreasing GFR.

• Key complication: If not addressed, AKI can progress to chronic kidney disease, leading to long-term kidney dysfunction, fluid overload, electrolyte imbalances, and increased risk for cardiovascular complications.

Patient Profile

Demographics:

58-year-old male, construction worker

History:

• Hypertension, Type 2 Diabetes, Chronic Back Pain

• Lisinopril, Metformin, Ibuprofen (as needed for back pain)

• No known drug allergies

Current Presentation:

• Chief complaint: Decreased urine output and fatigue

• Key symptoms: Nausea, mild swelling in legs, confusion

• Vital signs: Blood pressure 162/98 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, temperature 99.1°F, oxygen saturation 95% on room air

Section 1

The initial assessment findings reveal that the patient is experiencing significant fluid retention, as evidenced by mild swelling in his legs and decreased urine output. Upon further evaluation, the nurse notes that the patient's skin turgor is slightly diminished, indicating potential dehydration, which may be contributing to the prerenal AKI. Auscultation of the lungs reveals slight crackles at the bases, suggesting beginning pulmonary congestion. The patient's confusion is a concerning sign, possibly reflecting uremia due to the accumulation of waste products in the blood.

Laboratory results show an elevated serum creatinine level of 2.3 mg/dL (normal range: 0.6-1.2 mg/dL) and blood urea nitrogen (BUN) of 45 mg/dL (normal range: 7-20 mg/dL), confirming the declining kidney function. Electrolyte imbalances are present, with hyperkalemia noted at 5.8 mEq/L (normal range: 3.5-5.0 mEq/L), raising concerns for potential cardiac complications. Additionally, the patient's blood glucose level is elevated at 250 mg/dL, suggesting his diabetes is not well-controlled, which could exacerbate kidney damage.

The interdisciplinary team decides to initiate interventions aimed at improving renal perfusion and addressing fluid overload. This includes cautious IV fluid administration to correct dehydration while monitoring for signs of fluid overload. The patient's antihypertensive medication, Lisinopril, is temporarily withheld due to potential renal effects, and a nephrology consult is requested for further management. The team also considers adjusting the patient's diabetes management plan to optimize blood sugar control. There is an emphasis on careful monitoring of the patient's cardiac status due to the risk of dysrhythmias from hyperkalemia, setting the stage for potential further complications if the patient's condition does not stabilize.

Section 2

As the interdisciplinary team continues to closely monitor the patient, overnight developments indicate new complications. The morning assessment reveals that the patient's blood pressure has dropped to 88/56 mmHg, and his heart rate has increased to 112 bpm. These vital sign changes suggest potential hypovolemia or worsening cardiac function, despite the cautious fluid administration. The patient's urine output remains low, with only 200 mL recorded over the past 12 hours, indicating persistent oliguria. Upon reassessment, the crackles in the lungs have become more pronounced, now extending to the mid-lung fields, raising concerns about progressing pulmonary edema.

The latest laboratory results show further deterioration in renal function, with serum creatinine rising to 3.1 mg/dL and BUN climbing to 60 mg/dL. Hyperkalemia persists, with potassium levels now at 6.2 mEq/L, increasing the urgency of addressing the risk of cardiac arrhythmias. An ECG is performed, revealing peaked T-waves and a prolonged QRS complex, confirming the need for immediate intervention to stabilize the patient's cardiac status. Additionally, the patient's serum glucose remains elevated at 240 mg/dL, despite adjustments to his diabetes management, suggesting that further refinement is necessary to prevent additional renal stress.

In response to these developments, the team convenes to reassess the treatment plan. The nephrologist recommends the initiation of low-dose loop diuretics to alleviate fluid overload while continuing to monitor for electrolyte imbalances closely. Due to the escalating hyperkalemia, the team decides to administer calcium gluconate for cardiac membrane stabilization and considers using insulin and glucose to facilitate potassium shift back into the cells. Adjustments to the patient's diabetic regimen are also discussed, with the introduction of short-acting insulin to achieve better glycemic control. These interventions aim to stabilize the patient's condition and prevent further complications, setting the stage for ongoing monitoring and evaluation.

Section 3

The interdisciplinary team implements the revised treatment plan, administering a low-dose loop diuretic to address the fluid overload and calcium gluconate to stabilize the cardiac membranes. Insulin and glucose are also given to help shift potassium intracellularly, aiming to reduce the risk of life-threatening arrhythmias. Throughout the morning, the nursing team diligently monitors the patient for signs of improvement or further complications. By midday, there is a modest increase in urine output, with 150 mL recorded over the past four hours, suggesting a slight improvement in renal perfusion. However, the patient's blood pressure remains low at 90/58 mmHg, and heart rate continues to hover around 110 bpm, indicating persistent hemodynamic instability.

On reassessment, the crackles in the patient's lungs have slightly diminished, now localized to the lower lung fields, hinting at the initial effectiveness of the diuretic therapy. Despite these encouraging signs, the latest laboratory results reveal a mixed picture. Serum creatinine has slightly decreased to 2.9 mg/dL, and BUN is down to 55 mg/dL, suggesting a tentative stabilization of renal function. However, potassium levels remain elevated at 5.8 mEq/L, necessitating continued vigilance and potential further intervention to prevent recurrence of ECG changes. Blood glucose levels have improved slightly, now at 220 mg/dL, following the adjustment in insulin therapy, yet they remain above target.

As the team evaluates the patient's response to the interventions, they identify the need for continued close monitoring of fluid status, electrolyte balance, and cardiac function. Adjustments to the insulin regimen are considered to optimize glycemic control further and minimize renal stress. The primary focus remains on stabilizing the patient's condition, with the nephrologist and cardiologist collaborating to fine-tune the treatment plan. The team remains cautiously optimistic, aware of the delicate balance required to manage this complex case and prevent the emergence of new complications.

Section 4

As the afternoon progresses, the nursing team observes a change in the patient's status that warrants immediate attention. Despite the modest increase in urine output earlier, the patient begins to exhibit signs of increased respiratory distress. Oxygen saturation levels have dipped to 88%, and the patient is now requiring supplemental oxygen via a non-rebreather mask. Upon auscultation, crackles have returned to the mid-lung fields, and there is noted use of accessory muscles, indicating a potential exacerbation of pulmonary edema. The interdisciplinary team quickly convenes to reassess the treatment plan, considering the balance between diuretic therapy and the patient's hemodynamic status.

New diagnostic results provide additional insight into the patient's condition. An arterial blood gas analysis reveals a pH of 7.32, PaCO2 of 48 mmHg, and HCO3- of 24 mEq/L, indicating a respiratory acidosis likely due to impaired gas exchange from the fluid overload. Additionally, the patient's chest X-ray shows bilateral infiltrates consistent with pulmonary congestion. The nephrologist notes that while renal function shows tentative stabilization, the fluid management strategy requires adjustment to address the current respiratory compromise without further destabilizing blood pressure or worsening renal perfusion.

In response to these developments, the treatment plan is revised with a cautious increase in the diuretic dose, along with continuous renal replacement therapy (CRRT) as a potential option if renal function does not improve. The cardiologist suggests the use of a vasopressor to support blood pressure and enhance perfusion. The team decides to closely monitor the patient's electrolytes and cardiac rhythm, given the ongoing risk of hyperkalemia and arrhythmias. The patient's journey is at a critical juncture, as the team strives to balance fluid overload management with the need for hemodynamic stability, reinforcing the importance of dynamic clinical reasoning in this complex case.

Section 5

Following the interdisciplinary team's revised treatment plan, the nursing staff implements the cautious increase in diuretic therapy. Over the next few hours, urine output shows a modest increase, which initially provides a glimmer of hope for fluid clearance. However, the patient's respiratory status remains precarious. Despite the supplemental oxygen, the patient's oxygen saturation fluctuates between 85% and 89%. The use of accessory muscles persists, and the patient appears more fatigued, raising concerns about potential respiratory failure.

Further monitoring reveals a concerning trend: the patient's blood pressure begins to fall, now measuring at 88/54 mmHg. This hypotension raises alarms about the balance between fluid removal and circulatory adequacy. In light of these developments, the team decides to initiate low-dose vasopressor support to stabilize blood pressure while continuing to monitor renal function closely. Electrolyte panels indicate a rising potassium level, now at 5.8 mEq/L, necessitating the cautious administration of calcium gluconate and insulin with glucose to mitigate the risk of cardiac arrhythmias.

Concurrently, the nephrology team is preparing for the potential initiation of continuous renal replacement therapy (CRRT) should the patient's renal function fail to show improvement. The nursing staff remains vigilant, closely observing for any signs of further decompensation while providing detailed reports to the medical team. The situation underscores the importance of dynamic clinical reasoning and vigilant monitoring, as the team works to navigate this delicate balance between fluid management and hemodynamic stability. The patient's journey remains critical, with the next steps hinging on the collective expertise and timely intervention of the healthcare team.